Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

The Health Care Select Sector SPDR® ETF

MFS Growth Equity

Vanguard Institutional Index I

MFS Growth B

Fidelity Select Health Care

BGF World Healthscience A2

Janus Inst Mid Cap Growth CF

Janus Henderson Enterprise D

Fidelity Contrafund

Fidelity Select Medical Tech and Devcs

Vanguard PRIMECAP Inv

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

Capital Group Growth Fnd of Amer Comp

American Funds Growth Fund of Amer A

iShares Core S&P 500 ETF

Vanguard Growth Index Investor

Vanguard Health Care Inv

FMR Inc

Vanguard Group Inc

DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main

Capital World Investors

Bollard Group LLC

Morgan Stanley - Brokerage Accounts

NORGES BANK

HHG PLC

Franklin Resources Inc

Amvescap Plc.

Bank of New York Mellon Corp

Legal & General Group PLC

BlackRock Inc

State Street Corp

PRIMECAP Management Company

Wellington Management Company LLP

Geode Capital Management, LLC

Bank of America Corp

JPMorgan Chase & Co

Massachusetts Financial Services Company

Boston Scientific Corp

Mr. Michael F. Mahoney

Chairman, President & CEO

Mr. Daniel J. Brennan CPA

Executive VP & CFO

Mr. Joseph M. Fitzgerald

Executive VP & Group President of Cardiology

Mr. Jeffrey B. Mirviss M.B.A.

Executive VP & President of Peripheral Interventions

Mr. Arthur Crosswell  Butcher

Executive VP and Group President of MedSurg & Asia Pacific

Mr. John Bradley Sorenson

Executive Vice President of Global Operations

Ms. Emily  Woodworth

Senior VP, Global Controller & Chief Accounting Officer

Ms. Jodi Euerle Eddy

Senior VP and Chief Information & Digital Officer

Mr. Jonathan R Monson

Senior VP of Investor Relations

Mr. Vance R. Brown

Senior VP, General Counsel & Corporate Secretary

Boston Scientific Corp (BSX) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Boston Scientific Corp (BSX) Earnings Report Date and History | NYSE

BSX's next earnings is on January 29, 2025 (Before Market Open)

When is the earnings report for BSX?

BSX Earnings History

BSX Stock Discussion Forum and Message Board

News for NYSE: BSX